Empirically establishing drug exposure records directly from untargeted metabolomics data
bioRxiv [Preprint]. 2024 Oct 26:2024.10.07.617109. doi: 10.1101/2024.10.07.617109.
Published on October 17, 2024
ABSTRACT
Despite extensive efforts, extracting information on medication exposure from clinical records remains challenging. To complement this approach, we developed the tandem mass spectrometry (MS/MS) based GNPS Drug Library. This resource integrates MS/MS data for drugs and their metabolites/analogs with controlled vocabularies on exposure sources, pharmacologic classes, therapeutic indications, and mechanisms of action. It enables direct analysis of drug exposure and metabolism from untargeted metabolomics data independent of clinical records. Our library facilitates stratification of individuals in clinical studies based on the empirically detected medications, exemplified by drug-dependent microbiota-derived N-acyl lipid changes in a cohort with human immunodeficiency virus. The GNPS Drug Library holds potential for broader applications in drug discovery and precision medicine.
PMID:39416075 | PMC:PMC11482764 | DOI:10.1101/2024.10.07.617109
Latest Publications
- Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma
- XMD8-92 and JWG-045 exhibit anti-ferroptotic activities, independently of inhibiting ERK5
- Molecular Characterization of Extracellular Vesicles From Human B Cell Lymphomas: Methodological Comparison to Vesicles From Patient Serum
- Evolving epigenomics of immune cells at single-nucleus resolution in children en route to type 1 diabetes
- Restoring the tumour mechanophenotype of vocal fold cancer reverts its malignant properties